Furthermore, responders and non-responders exhibited significantly different preoperative SUVmax and TBR, regardless of the treatment response classification (i.e., pCR/RD or RCB index) across different BC subtypes and HER2 expression patterns. The gene discussed is ERBB2; the disease is breast cancer.